October 31, 2025 - 18:22

Local organizers are intensifying their efforts to persuade Minneapolis Mayor Jacob Frey to terminate the city's contract with an Israeli technology company that supports police surveillance initiatives. The contract has come under scrutiny as community members express concerns about privacy violations and the implications of foreign surveillance technology being used in local policing.
Protesters argue that the use of such technology exacerbates issues of racial profiling and civil rights infringements, particularly in marginalized communities. They believe that relying on foreign surveillance tools undermines trust between residents and law enforcement. Activists have been vocal at city council meetings, demanding transparency and accountability in the decision-making process surrounding the use of these technologies.
The movement has gained traction, with numerous community groups uniting to call for a reevaluation of the city's approach to policing and surveillance. As public pressure mounts, the future of the contract remains uncertain, with many hoping for a shift towards more community-focused policing strategies.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...